Orient Pharmaceutical Co., Ltd. 2023 Annual Equity Distribution Implementation Notice
Orient Pharmaceutical Co., Ltd. 2023 Profit Distribution Plan Announcement
Announcement of Orient Pharmaceutical Co., Ltd. on the 2022 Restricted Stock Incentive Plan, First Release Period, Release Restriction Conditions, Achievements in Releasing Sales Restrictions, and Listing Circulation
Legal Opinion of Attorney Guohao (Hangzhou) Firm on matters relating to the first lifting of the sales restriction period and the adjustment of repurchase prices in the 2022 restricted stock incentive plan of Orient Pharmaceutical Co., Ltd.
Announcement on the listing and circulation of some restricted shares in the initial public offering of Orient Pharmaceutical Co., Ltd.
Orete Pharmaceutical Co., Ltd. 2022 Annual Equity Distribution Implementation Notice
Announcement of Orete Pharmaceutical Co., Ltd. on the 2022 profit distribution plan
Shareholder dividend return plan for the next three years of Orete Pharmaceutical Co., Ltd. (2023-2025)
Announcement of Orete Pharmaceutical Co., Ltd. on the award results of the 2022 restricted stock incentive plan
Orete: List of incentive targets for Orete Pharmaceutical Co., Ltd. 2022 Restricted Stock Incentive Plan (award date)
Orete: Legal opinion from Guohao Lawyers (Hangzhou) Firm on matters relating to the grant of the 2022 Restricted Stock Incentive Plan of Orete Pharmaceutical Co., Ltd.
Orete: Announcement by Orete Pharmaceutical Co., Ltd. on awarding restricted shares to the incentive targets of the company's 2022 restricted stock incentive plan
Orete: Audit opinion of the Supervisory Board of Orete Pharmaceutical Co., Ltd. on matters relating to the grant of the company's 2022 restricted stock incentive plan
Orete: Announcement by Orete Pharmaceutical Co., Ltd. on adjusting the list of incentive targets and grants for the company's 2022 restricted stock incentive plan
Announcement of Orete Pharmaceutical Co., Ltd. on adjusting the list and number of incentive targets for the company's 2022 restricted stock incentive plan
Inspection opinions of the supervisory board of Orete Pharmaceutical Co., Ltd. on matters relating to the grant of the company's 2022 restricted stock incentive plan
Legal opinion of Guohao Law Firm (Hangzhou) on matters relating to the grant of the 2022 Restricted Stock Incentive Plan of Orete Pharmaceutical Co., Ltd.
Announcement of Orete Pharmaceutical Co., Ltd. on awarding restricted shares to the incentive targets of the company's 2022 restricted stock incentive plan
List of incentive targets for Orete Pharmaceutical Co., Ltd. 2022 Restricted Stock Incentive Plan (award date)
Orete: Orete Pharmaceutical Co., Ltd.'s self-inspection report on the company's 2022 restricted stock incentive plan insider information on how insiders traded the company's shares
No Data